2004; Rees et al, 2010) . Vascular dysfunction has also been shown to be involved in several SS-related complications (Gladwin et al, 2004; Kato et al, 2007) . Several studies have suggested that increased haemolysis and oxidative stress may play a major role in the development of chronic vasculopathy in SS (Reiter et al, 2002; Morris et al, 2005; Kato et al, 2006 Kato et al, , 2007 Nur et al, 2011; Chirico & Pialoux, 2012) .
Sickle cell haemoglobin C disease (SC) has long been considered to be a mild variant of sickle cell disease. However, retinopathy and otological disorders were found to occur more frequently in patients with SC than SS patients (Lionnet et al, 2012) . Furthermore, evidence suggests that a significant proportion of patients with SC are likely to develop glomerulopthy, osteonecrosis, priapism and vaso-occlusive crises (Hannemann et al, 2011; Lionnet et al, 2012; Lemonne et al, 2014a) . In SC, abnormal blood rheology seems to contribute to clinical outcomes and severity (Lemonne et al, 2014b) . However, few studies have focused on vascular function in SC (Mohan et al, 2011) . Moreover, the influence of oxidative stress and haemolysis level on the vascular function of patients with SC disease is still unknown.
In this context, this study aimed to determine whether microvascular reactivity, blood viscosity, levels of several vasoactive molecules and several biomarkers reflecting haemolysis and oxidative stress differed between children with SS and SC disease and to determine the associations between these parameters. Moreover, in order to define the degree of vascular dysfunction and of oxidative stress in SC children, as well as in SS children, oxidative stress and vascular function markers were compared to those of wellmatched healthy children (AA).
Methods

Patients
Forty-three sickle cell children/adolescents, all native Guadeloupeans, were recruited from the Sickle Cell Unit of the Academic Hospital of Pointe-a-Pitre (Guadeloupe) where they have been regularly followed since birth. Twenty (11 girls, nine boys) patients with SS disease and 23 (nine girls, 14 boys) patients with SC disease participated in this study. All patients were volunteers and gave written consent before participating in the study. Written informed consent was also obtained from the parent or guardian of each child. They were in steady state at the time of the study (i.e., no blood transfusion within the last 3 months, absence of acute episodes of infection, vaso-occlusive crisis or acute chest syndrome at least 1 month before inclusion in the study). Five SS patients had been receiving hydroxycarbamide (also termed hydroxyurea) treatment for more than 6 months (dose c. 20 mg/kg/day). Twelve well matched non-sickle children, all native Guadeloupeans, participated as controls. The study was approved by the Regional Ethics Committee (CPP SudOuest Outre-Mer III, Bordeaux, France, registration number:
2009-A00211-56/2013, SAPOTILLE/HYPOSNAD project) and conducted in accordance to the Declaration of Helsinki.
Blood samples
Venous blood was sampled at baseline in the sitting position from the antecubital vein into EDTA tubes before vascular function measurement. Haematological parameters and blood viscosity were measured within 1-2 h after sampling and full reoxygenation (Baskurt et al, 2009) in sickle cell children. After centrifugation, plasma was extracted and used for the determination of oxidative stress markers, endothelin-1 (ET-1, also termed EDN1) and nitric oxide (NO) metabolites.
Haematological and blood viscosity measurements
Haematological data were obtained using an automated cell counter (MAXM AL; Beckman Coulter, Miami, FL, USA). Blood viscosity was measured at native haematocrit and at room temperature (25°C) using a cone-plate viscometer (Brookfield DVII+ with CPE40 spindle; Brookfield Engineering, Natick, MA, USA) at 225/s. Measurements were performed according to the recent international guidelines for haemorheological laboratory techniques (Baskurt et al, 2009) . Biochemical parameters reflecting haemolysis were determined by standard methods: serum lactate dehydrogenase, total bilirubin, aspartate aminotransferase levels and percentage of reticulocytes. Of these four haemolytic parameters, one resuming variable (haemolytic index) was calculated by principal component analysis, as reported previously (Nouraie et al, 2013) . This standard statistical approach is appropriate when several biological measurements reflect similar aspects of a single underlying process (Genser et al, 2007) .
Oxidative stress, nitric oxide and endothelin-1 plasma markers Because of high reactive instability, reactive oxygen species (ROS) production cannot be easily and directly measured in plasma. Assessment of oxidative stress was therefore based on the measurement of more stable plasma products of oxidative reactions and of plasma antioxidant defences (Nur et al, 2011) .
Plasma biomarkers of oxidative stress [advanced oxidation protein products (AOPP), malondialdehyde (MDA)], antioxidant status [catalase, glutathione peroxidase (GPX), and superoxide dismutase (SOD) activities, ferric reducing antioxidant power (FRAP)], NO markers [NO end-products (NOx), sum of nitrite and nitrate and nitrotyrosine] and ET-1 were determined by spectrophotometry on a microplate reader (Infinite M200; Tecan, M€ annedorf, Switzerland).
Plasma AOPPs. AOPPs were determined using the semiautomated method developed by Witko-Sarsat et al (2003) , as previously described (Diaw et al, 2015) . MDA. Concentrations of plasma MDA were determined as previously described (Diaw et al, 2015) using a modified method reported by Ohkawa et al (1979) based on thiobarbituric acid reactions.
Catalase. Plasma Catalase activity, represented by the formation rate of formaldehyde, was determined by the method of Johansson and Borg (1988) .
GPX. Plasma GPX activity was identified by the modified method of Paglia and Valentine (1967) SOD. SOD activity was evaluated using a previously reported method (Oberley & Spitz, 1985) ,which employs the hypoxanthine-xanthine oxidase system. Superoxide radical production is observable using nitroblue tetrazolium colouration.
FRAP. FRAP was measured as previously described (Diaw et al, 2015) based on the ferric-reducing ability of plasma (Benzie & Strain, 1999) .
NOx. NO end products (NOx) were measured using the Griess method (Misko et al, 1993) . Nitrate reductase and NADPH were added to plasma in order to reduce nitrate to nitrite.
Nitrotyrosine. Concentrations of plasma nitrotyrosine, as the end product of protein nitration induced by peroxynitrite, were measured using a competitive enzyme-linked immunosorbent assay (ELISA) as previously described (Galinanes & Matata, 2002) .
ET-1. ET-1 is a potent vasoconstrictor produced mainly by endothelial cells. Circulating ET-1 levels were determined in sickle cell children only, as previously reported (Ergul et al, 1996) , using an ELISA kit specifically designed for measurement of plasma ET-1 (American Research Product, Inc., Waltham, MA USA).
Assessment of microvascular function
Peripheral microcirculatory cutaneous blood flow and microvascular response to local heating of the middle finger of the left hand was evaluated, as previously described (Roustit & Cracowski, 2012) using a Laser Doppler flowmeter (Periflux System 5000; Perimed, J€ arf€ alla, Sweden) and its associated software Perisoft (Perimed). A combined laser Doppler and thermostatic metallic probe (PR457) was attached to the distal pad of the middle finger of the left hand. This device enables skin blood flow recording (mV) and is a simple, non-invasive method (Roustit & Cracowski, 2012) . The same operator placed the metallic probe in all patients, in order to reduce spatial variability due to vessels' anatomy. Children were well matched to limit ethnical, gender and age influences on skin blood flow. The advantages and limitations of this method have been previously described (Roustit & Cracowski, 2012) .
After a 10-min baseline recording to allow patients/subjects acclimation and to limit the effects of mental stress on microcirculatory blood flow, the skin temperature was raised to 42°C (within 5 s) and the microvascular response to local heating was measured for 40 min. Participants were asked to avoid any movement of the left hand until the reactivity test was completed. Local cutaneous heating results in a biphasic increase in blood flow: a rapid increase (initial peak), related to axon reflex, followed by a nadir and a prolonged plateau, mainly NO-dependent (Minson et al, 2001; Roustit & Cracowski, 2012) . Taking into account any individual fluctuations of skin blood flow (due to blood pressure changes), laser Doppler blood flow (recorded in mV) was divided by the individual mean arterial pressure. Indeed, baseline blood flow, initial peak and the plateau were expressed as cutaneous vascular conductance (CVC, mV/mmHg) (Boignard et al, 2005) . The increase in blood flow from baseline to peak or plateau, expressed as a percentage, represented the capacity of vessels to dilate, as previously reported (Roustit & Cracowski, 2012) . Heart rate (beats/min), resting diastolic blood pressure (mmHg) and resting systolic blood pressure (mmHg) were also recorded.
Statistical analysis
Results are presented as mean AE standard deviation or median (25th and 75th percentiles). Anthropometric, physiological, haematological parameters and ET-1 levels were compared between SC and SS children using unpaired Student t test or Mann-Whitney comparison test for non-parametric parameters. Parametric or non-parametric correlation tests (Pearson or Spearman, respectively) were performed in order to test whether microvascular function/dysfunction level and biological parameters were associated. Microvascular function and oxidative stress/NO markers were compared between the AA, SC and SS children using a one-way ANOVA and Turkey honest significant difference post hoc test or the non-parametric Kruskal-Wallis ANOVA followed by a MannWhitney test. The significance level was defined as P < 0Á05. Analyses were conducted using SPSS (v. 20; SPSS Statistics, Chicago, IL, USA) and Statistica (Statistica, v5.5; Statsoft, Tulsa, OK, USA). Graphs were drawn using GraphPad Prism (v. 7, Graph Pad Software for mac; GraphPad Software Inc., San Diego, CA, USA).
Results
Anthropometric and haematological characteristics
Anthropometric characteristics were not significantly different between SS and SC children (Table I) . Haemoglobin, haematocrit levels and blood viscosity were significantly lower in children with SS than in children with SC disease (P < 0Á001, Table I ). Haemolytic parameters (lactate dehydrogenase, total bilirubin, reticulocytes, aspartate aminotransferase content, haemolytic index) and fetal haemoglobin were significantly higher in SS compared to SC patients (P < 0Á05, Table I ).
Oxidative stress and antioxidant status SS and SC children had increased MDA and AOPP levels compared to healthy controls (Fig 1) . MDA did not differ between SS and SC but AOPP was higher in SS group (P < 0Á01, Fig 1) . SOD activity was higher in SS (P < 0Á01) and SC (P < 0Á05) than in AA children. Catalase activity was lower in SC than in SS (P < 0Á05) and AA (P < 0Á001) children (Fig 1) . GPX (P < 0Á01) was significantly increased in SS patients compared to the SC group (Fig 1) . The SS group had higher levels of FRAP compared to both AA and SC children (P = 0Á001), while FRAP level was higher in SC than in AA (P < 0Á001). In patients with SS, total bilirubin concentrations were positively correlated with plasma AOPP (P < 0Á01, r = 0Á54) and FRAP content (P < 0Á01, r = 0Á66).
In SC children, total bilirubin level was correlated with total antioxidant power (P < 0Á01, r = 0Á66). Furthermore, in SC, AOPP was associated with Catalase (P < 0Á001, r = 0Á775) and FRAP (P = 0Á05, r = 0Á406).
Haemolytic index did not correlate with any vascular function and oxidative stress parameters in both groups. Nevertheless, in SS children, the haemolytic index tended to be associated with AOPP (P = 0Á065, r = 0Á391). Haematocrit level was negatively associated, exclusively in SS group, to AOPP (P < 0Á01, r = À0Á63). Oxidative stress grade did not differ between the five SS children receiving hydroxycarbamide and those without (data not shown).
Plasma levels of NOx, nitrotyrosine and ET-1
NOx were similar in SS and SC but both groups had higher levels than AA (P < 0Á001). Nitrotyrosine was significantly higher in SS patients compared to SC (P < 0Á05, Fig 1) and AA (P < 0Á01, Fig 1) . ET-1 concentration tended to be higher in SS compared to SC children: 3Á35 AE 1Á57 vs. 2Á55 AE 1Á31 pg/ml, respectively (P = 0Á056). In children with SS disease, nitrotyrosine correlated with haemoglobin (P < 0Á05, r = À0Á48) and haematocrit (P < 0Á05, r = À0Á43) level.
Microvascular function
Baseline blood flow was significantly higher in SS than in SC (P < 0Á05) and AA (P < 0Á01) children. In response to local heating, peak and plateau blood flow were not different between the three groups (Fig 2) . However, when expressed as a percentage, the increase of skin blood flow up to peak was lower in both SS (P < 0Á01) and SC (P < 0Á05) than in AA but was not statistically different between SS and SC: 414Á5 (124; 892) %, 74Á55 (36Á61; 150Á44) % and 74Á52 (29Á23; 206Á28) %, in AA, SC and SS children, respectively. The percentage of blood flow increase up to the plateau was higher in AA (P < 0Á001) and SC (P < 0Á05) than in SS patients: 291Á5 (203; 767) %, 90Á96 (50Á71; 198Á42) % and 34Á95 (À0Á93; 70Á58) % in AA, SC and SS children, respectively.
Given that blood flow may be affected by the degree of anaemia, baseline blood flow and both peak and plateau responses were corrected by the haematocrit in SS and SC (haematological parameters were not available in AA). After haematocrit correction, microvascular function parameters were compared between the two groups. The results demonstrated that baseline blood flow remained higher (0Á06 AE 0Á04 vs. 0Á11 AE 0Á06, P < 0Á05 in SC and SS, respectively) and microvascular reactivity remained lower in SS compared to SC children (blood flow increase up to plateau: 75 (29; 206)% vs. 35 (À1; 70)%, P < 0Á05 in SC and SS, respectively). In addition, no correlation was observed between haematocrit/haemoglobin level and vascular reactivity or baseline blood flow. Plasma nitrotyrosine (P < 0Á05, r = À0Á62), NOx (P < 0Á05, r = À0Á56) and AOPP (P < 0Á05, r = À0Á45) were negatively correlated with the blood flow increase up to the plateau in SS children but not in SC patients. ET-1 level did not correlate with vascular function in both groups. The vascular reactivity of SS children receiving hydroxycarbamide treatment did not differ from SS children not receiving hydroxycarbamide (data not shown).
Discussion
The major results of this study are: (1) microvascular reactivity in response to local heating was impaired in SS and SC children compared to AA children with the degree of impairment being higher in SS than in SC patients, (2) oxidative stress and antioxidant enzyme activities were elevated in both SS and SC groups compared to AA children but oxidative stress was less severe in SC than in SS children, (3) haemolysis and nitrotyrosine level were increased in SS compared to SC (and AA for nitrotyrosine), (4) microvascular function correlated with oxidative and nitrosative stress in SS but not in SC children. Comparison of oxidative stress-, antioxidant status-and nitric oxide metabolism parameters between sickle cell SC and SS and non sickle, AA children. AA, healthy children with normal haemoglobin; SS, children with homozygous sickle cell disease; SC, children with sickle cell haemoglobin C disease; AOPP, advanced oxidation protein products; MDA, malondialdehyde; SOD, superoxide dismutase; GPX, glutathione peroxidase; FRAP, ferric reducing antioxidant power. *P < 0Á05 versus SC; **P < 0Á01 versus SC; ***P < 0Á001 versus SC; # P < 0Á05 versus AA; ## P < 0Á01 versus AA; ### P < 0Á001 versus AA .   Fig 2. Baseline, initial thermal peak and plateau cutaneous vascular conductance (CVC) in children with sickle haemoglobin C disease (SC) and sickle cell anaemia (SS) and with normal haemoglobin A (AA). All data are presented as mean AE standard deviation. *P < 0Á05 versus SC; ## P < 0Á01 versus AA.
Self-regulation of blood vessel diameter, in response to shear stress and various biological stimuli, facilitates the maintenance of adequate tissue perfusion throughout the vascular system (Segal, 1994) . NO-mediated vasodilation and ET-1-mediated vasoconstriction are important antagonists of endothelium-dependent vasomotor control (Baskurt et al, 2004) . Thus, disruption of this balance may lead to structural and functional vascular changes associated with perfusion alterations.
Elevated plasma free haemoglobin (Reiter et al, 2002 ) and plasma arginase-1 content (Morris et al, 2005) , due to increased haemolysis, have been reported to limit NO bioavailability in SS patients (Kato et al, 2007) . As expected, haemolysis was higher in SS than in SC children. Haemolytic rate and anaemia are known to be milder in SC than in SS compared to AA individuals (Ballas et al, 1982) . Thus, it was not surprising that SS children had reduced NO-dependent vasodilation (plateau phase of the thermal hyperaemic response) compared to SC and AA children. However, the SS and SC populations had similar resting NOx levels, though we could have expected to find impaired NO bioavailability in SS subjects. Nevertheless, endothelial NO synthase activity has been reported to be increased in transgenic sickle mice compared to controls (Bank et al, 1996; Kaul et al, 2000) , probably as a result of the chronic high shear stress applied to the endothelial cells (Kaul et al, 2000; Belhassen et al, 2001) . Vascular wall shear stress has never been assessed in SC patients. However, although blood viscosity was 20% greater in SC children compared to SS, baseline skin blood flow was 40% lower in the SC group, which could lead to lower wall shear stress in this group. The subsequent lower mechanical stimulation of endothelial NO synthase activity in SC could thus result in lower NO production compared to SS children. However, the higher plasma nitrotyrosine content found in SS children suggests that the extra NO, that could possibly be produced, would probably be rapidly converted into peroxynitrite by reacting with superoxide radicals, thereby reducing the impact of NO on vasodilation. The correlation found between AOPP and nitrotyrosine supports a role of oxidative stress in the decrease of NO bioavailability in SS children.
Interestingly, in SS, plasma nitrotyrosine level was also negatively correlated with the percentage change in blood flow between baseline and plateau. Peroxynitrite may exert deleterious effects on the vascular function of SS children, as previously described in other disease cases (Szabo et al, 2007) . In addition, the higher ET-1 levels in SS compared to SC children, could participate in the loss of microvascular reactivity and vascular tone imbalance in SS. Repeated periods of sickling and hypoxia, pain intensity and NO depletion -all exacerbated in SS patients (Stuart & Nagel, 2004) -are known to promote sympathetic nervous system activity and ET-1 production (Lapoumeroulie et al, 2005; Steinberg et al, 2009) .
Conversely, in the SC group no correlation between vascular function parameters and nitrotyrosine was found. Although SC children showed impaired thermal hyperaemic peak response compared to the AA group, the plateau response was not significantly different between the two groups. Our findings suggest that the NO-related vasodilation during the thermal hyperaemic challenge is better preserved in SC than in SS children. The degree of anaemia may influence blood flow and vascular reactivity (Belhassen et al, 2001) . Our study demonstrated that despite haematocrit adjustment, microvascular reactivity remained lower in SS than in SC children. In addition, no association was observed between the degree of anaemia and microvascular reactivity. Indeed, the loss of vascular reactivity does not seem to be modulated by anaemia only. Our findings are in agreement with the study of Nur et al (2009) who previously reported that neither increased cerebral blood flow velocity, nor decreased cerebrovascular responsiveness to carbon dioxide was related to the degree of anaemia in SS (Nur et al, 2009) .
Five of the 23 SS children were under hydroxycarbamide treatment. Hydroxycarbamide is supposed to increase NO bioavailability (King, 2004) , which could probably improve vascular function. The comparison between these two subgroups did not show any difference in the magnitude of oxidative stress and microvascular dysfunction. Prospective studies in larger cohorts would be necessary to clarify this result.
Enzymatic antioxidant activity and capacity has been widely studied in patients with homozygous sickle cell disease (Das & Nair, 1980; Adelekan et al, 1989; Natta et al, 1990; Goswami & Ray, 2011; Chirico & Pialoux, 2012; El-Ghamrawy et al, 2014) and in murine models of sickle cell disease (Dasgupta et al, 2006; Charrin et al, 2015) compared to controls. However, to the best of our knowledge no study has previously compared enzymatic antioxidant activity between SS, SC and AA children. According to our findings, SS and SC groups had elevated oxidative stress levels and upregulated enzymatic antioxidant activities, compared to healthy controls. Compared to SC children, SS had greater levels of GPX, Catalase and FRAP along with higher plasma AOPP concentrations, suggesting higher ROS generation in SS children. Indeed, the increased antioxidant activity was probably not sufficient to entirely counterbalance the overproduction of ROS (Chirico & Pialoux, 2012) in SS patients. In contrast to SS children, oxidative stress markers correlated well with each other in the SC group, probably underlying a more equilibrated balance between oxidants and antioxidants. The source of oxidative stress in sickle cell disease is multiple (Chirico & Pialoux, 2012) . The positive correlation observed between haemolytic markers and AOPP plasma levels observed in SS, but not in SC patients, suggests that elevated oxidative stress is probably partly related to increased haemolysis in SS children. Furthermore, the expected higher amount of haemoglobin released into the plasma of SS children, a mechanism thought to be one of the main sources of ROS production in the context of sickle cell disease (Voskou et al, 2015) , may also contribute to the higher oxidative and nitrosative stresses in the SS group. In conclusion, microvascular function is better preserved in SC than in SS young patients compared to healthy children. The mild haemolysis found in SC compared to SS children may limit oxidative and nitrosative stresses, which may further preserve microvascular function. These results could explain why SC patients may develop leg ulcers, pulmonary hypertension, priapism or stroke less frequently than SS patients (Kato et al, 2007) . Instead, higher blood viscosity in SC could increase the risks for retinopathy, otological disorders and osteonecrosis, as previously described (Lemonne et al, 2014b) .
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